e-Newsletters for Patients

Columbia University Medical Center to Lead New Treatment Trial for Fatty Liver Disease

The Division of Pediatric Gastroenterology at Morgan Stanley Children's Hospital/Columbia University Medical Center is leading a new clinical trial of cysteamine bitartrate as a potential treatment of non-alcoholic steatohepatitis (NASH), an advanced form of non-alcoholic fatty liver disease.More

  • Bookmark
  • Print


eNewsletters
Top of page